Category: Artificial Intelligence

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

The Sunshine Act was passed by the US Govt. in 2010 to increase transparency in financial payments made by Drug Manufacturers or GPOs to healthcare providers and teaching hospitals. In compliance with this act, the resulting data, which is known as Open Payments Data, is released by CMS on June 30th every year. Apart from […]

The United States Department of Justice made an annual announcement on December 14, 2016 in which the amount of money that was recovered in 2016 in Civil False Claims Act settlements and judgments during the fiscal year 2016 were reported. As per the announcement, the DoJ recovered over $4.7 billion from businesses and individuals who […]

Although physician consent requirements are widespread across Europe, the fact is that different EU member countries have different rules surrounding the issue. Out of all, around 14 countries have a law or code in place, five countries (including France, Portugal, Romania, Netherlands, and Denmark) do not require consent, five countries (including Greece, Austria, Luxembourg, Hungary […]

Law enforcement authorities have indicted executives and physicians affiliated with the physician-owned Forest Park Medical Center for allegedly paying or accepting bribes and kickbacks in exchange for referring patients to the hospital. According to an announcement released by the Department of Justice, top-level executives and doctors affiliated with the hospital had established shell companies and […]

Pharma companies made $7.15 billion worth of ‘transfers of value’ in 2015 to physicians and hospitals. With all that wealth of industry data made publicly available through the Federal Open Payments program, the Department of Justice (DoJ) and federal and state prosecutors have sprung into action to investigate fraud across the healthcare system. This treasure […]

Gaining physician consent for data disclosure purposes under the EFPIA disclosure code is never easy. However, considering that the acquisition of consent is part of the law under the Directive 95/46/EC on the protection of individuals with regard to the processing of personal data, this is something pharma companies in the EU cannot overlook. With HCP’s […]